OR5AL2P

Across TCGA pan-cancer cohorts, OR5AL2P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR5AL2P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR5AL2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5AL2P expression acts as an unfavorable survival marker.

BLCA, THYM, and LAML are the cancer types where OR5AL2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.170	0.629	<.001	99	view →
THYM	OS	Tertile	All	0.169	0.931	<.001	99	view →
LAML	DFS	Tertile	All	0.207	0.587	.049	18	view →
COAD	DFS	Tertile	IV	0.028	0.496	<.001	18	view →
UCEC	DFS	Tertile	III,IV	0.085	0.582	.014	18	view →
GBM	OS	Tertile	All	0.121	0.415	.042	9	view →
SARC	DFS	Tertile	All	0.135	0.599	.001	9	view →
LUAD	OS	Tertile	III,IV	0.235	0.677	.030	9	view →
BRCA	OS	Tertile	All	0.218	0.581	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR5AL2P–BLCA (DFS)

Open the BLCA breakdown →